HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development and evaluation of dexamethasone nanomicelles with potential for treating posterior uveitis after topical application.

AbstractPURPOSE:
This study aims at the development and preliminary evaluation of dexamethasone nanomicelles for treating posterior uveitis. Nanomicelles were formulated using polyoxyl 40 stearate (P40S) and polysorbate 80 (P80), which are approved by the FDA for ocular use.
METHODS:
Dexamethasone nanomicelles were prepared and characterized for critical micellar concentration, solubility of dexamethasone, particle size, surface charge, morphology, in vitro drug release, clarity, stability, filtration efficiency, and sterility. Ocular tolerance and the tissue drug distribution of dexamethasone were assessed in rabbits after single and multiple topical administration.
RESULTS:
Dexamethasone nanomicelles (0.1% w/v) were successfully developed and characterized with an optimized composition of P40S/P80=7/3 by weight. The mean diameter of blank and drug-loaded nanomicelles was 13.3±0.4 and 14.5±0.4 nm, respectively. Transmission electron microscopy images revealed the spherical structure of nanomicelles. Nanomicelles were found to be stable with respect to clarity, size and drug content at 4°C and 25°C for up to 6 months. No irritation or redness was observed in the treated eyes as compared with the untreated control rabbit eyes. Therapeutic concentrations of dexamethasone were observed in the retina and choroid after single and multiple topical application in rabbits.
CONCLUSION:
In conclusion, the nanomicelles of P40S and P80 could efficiently solubilize 0.1% dexamethasone in their cores. The results also indicate that mixed nanomicelles could be utilized as a potential delivery system for delivering dexamethasone to treat the back of the eye diseases such as posterior uveitis after topical application.
AuthorsSoohi Patel, Chandrasekhar Garapati, Pallabita Chowdhury, Himanshu Gupta, Jerry Nesamony, Surya Nauli, Sai H S Boddu
JournalJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics (J Ocul Pharmacol Ther) Vol. 31 Issue 4 Pg. 215-27 (May 2015) ISSN: 1557-7732 [Electronic] United States
PMID25839185 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucocorticoids
  • Micelles
  • Dexamethasone
Topics
  • Administration, Ophthalmic
  • Animals
  • Calorimetry, Differential Scanning (methods)
  • Dexamethasone (administration & dosage, chemistry, pharmacokinetics)
  • Drug Delivery Systems
  • Glucocorticoids (administration & dosage, chemistry, pharmacokinetics)
  • Male
  • Micelles
  • Microscopy, Electron, Transmission (methods)
  • Nanoparticles (administration & dosage, chemistry)
  • Rabbits
  • Solubility
  • Uveitis, Posterior (drug therapy, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: